Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanCombined Modality TherapyGranulocyte Colony-Stimulating FactorLeukapheresisHematologic NeoplasmsAntigens, CD34Antineoplastic Combined Chemotherapy ProtocolsBlood Component RemovalCyclophosphamideStem Cell TransplantationMultiple MyelomaMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeNephritisLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalEtoposideThiotepaHematopoietic Stem CellsAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCarmustineCytophagocytosisIfosfamideSalvage TherapyVincristineAmyloidosisDisease-Free SurvivalCytarabineHodgkin DiseaseStem CellsHematopoiesisCord Blood Stem Cell TransplantationNeoplasmsSurvival RateTransplantation ChimeraRetrospective StudiesTissue DonorsDoxorubicinSurvival AnalysisWhole-Body IrradiationTime FactorsInfectionLymphoma, T-CellGlomerulonephritisCarboplatinKidney GlomerulusPlatelet CountHistocompatibilityPOEMS SyndromeProteinuriaAntineoplastic AgentsPrednisoneHistocompatibility TestingLeukemia, Myeloid, AcuteImmunosuppressive AgentsDexamethasoneFollow-Up StudiesTransplantation, IsogeneicVidarabineBlood Cell CountRecombinant ProteinsLeukemiaBone Marrow PurgingComplement C3LymphomaProspective StudiesBlood Transfusion, AutologousFatal OutcomeFeasibility StudiesBlood CellsCytomegalovirus InfectionsGraft vs Leukemia EffectBasement MembraneMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticPrognosisBreast NeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationT-LymphocytesLymphocyte DepletionLeukocytes, MononuclearPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic DiseasesBone MarrowOpportunistic InfectionsHistiocytosis, Non-Langerhans-CellLivedo Reticularis